RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENT
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HT009026FH050
- Contractor
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Health Agency
- Award amount
- $21,652
- Period of performance
- Apr 20, 2026 – Sep 30, 2026
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- PSC
- PSC Q517
- Place of performance
- MA
- Parent award
- 36F79719D0170
Public award description
RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENT
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.